Genzeon Wins UiPath Healthcare and Life Sciences Partner Award
Genzeon said in a press release that it was named UiPath's 2026 Industry Impact Partner of the Year for Healthcare and Life Sciences. The award was presented at UiPath FUSION 2026 and recognized work across prior authorization, referrals, claims and revenue cycle management.
Genzeon says that for the CMS WISeR program the companies delivered prior authorization infrastructure processing more than 450,000 cases annually across 17 high risk service categories, automating 85% to 90% of routine determinations while meeting 72 hour turnaround requirements and FHIR and CMS-0057-F compliance.
Genzeon reports that at a pediatric health system a referral workflow reduced processing time from about six minutes to less than one minute and saved an estimated 2,250 staff hours per month. It also reports that for a national complex rehabilitation provider automated prior authorization coverage expanded from four payers to more than 100, while manual touches fell by 70% to 80% and errors declined by 90% to 95% during the first phase.
The companies have worked together for five years. Genzeon reports that the partnership has deployed more than 45 AI agents in production and delivered more than 5,000 healthcare automation components.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 24 Anthropic Says Claude Identified an Uncharacterized Enzyme System Sep 24 AdminaHealth Adds AI Data Assistant to Enterprise Billing Suite Sep 23 Oracle and Buck Institute Use Health Data for Aging Research Sep 23 Oracle Health Plans AI Tools for Revenue Cycle Management Sep 23 Theranica AI Predicts Next Day Migraine Risk With 91.2% PrecisionLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
IDC Names ZS a Leader in Life Sciences Evidence Services
AmerCareRoyal Deploys qBotica Automation Across Four Companies
MegazoneCloud Builds Quality Assurance AI Agent for Hanmi Pharmaceutical
Knowtion Health and Ghamut Apply AI to Medical Claims Appeals
Kairon Health Raises $5 Million for AI Care Operations Platform
Daily AI Brief: the AI news that matters, in your inbox.